Rosacea Subtype-Specific Treatment Approaches
Key Findings
Tailored therapy based on rosacea subtype achieved 72% improvement vs 43% with standard approach. Combination therapy most effective.
Summary
Tailored therapy based on rosacea subtype achieved 72% improvement vs 43% with standard approach. Combination therapy most effective.
Study Design
Retrospective analysis of 520 rosacea patients stratified by subtype with personalized treatment protocols.
Methods
Subtype classification: erythematotelangiectatic, papulopustular, phymatous, ocular. Treatments matched to predominant features.
Results
Subtype-specific approach: 72% good-excellent response vs 43% standard. Combination topical/oral: 81% vs 58%.
Conclusions
Subtype-specific rosacea treatment yields superior outcomes. Combination therapy recommended for moderate-severe cases.
Full Abstract
This study examined rosacea subtype-specific treatment approaches in a comprehensive clinical investigation.